| Mrs Sarah Elizabeth Farrell, RN | |
|
11335 S 204th St, Gretna, NE 68028-7871 | |
| (402) 332-3936 | |
| Not Available |
| Full Name | Mrs Sarah Elizabeth Farrell |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - School |
| Location | 11335 S 204th St, Gretna, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033725882 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WS0200X | Registered Nurse - School | 58718 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Sarah Elizabeth Farrell, RN 11335 S 204th St, Gretna, NE 68028-7871 Ph: (402) 332-3936 | Mrs Sarah Elizabeth Farrell, RN 11335 S 204th St, Gretna, NE 68028-7871 Ph: (402) 332-3936 |
News Archive
Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has entered into a new, three year distribution agreement with Thimar Al Jazirah Health Care, based in Riyadh, Kingdom of Saudi Arabia, for the distribution of the SonaStar(TM) Ultrasonic Surgical Aspirator and the BoneScalpel(TM) Ultrasonic Bone Cutter.
Lawmakers and supporters are renewing efforts to bring $7.4 billion in aid to sickened and injured 9/11 workers, The Associated Press reports.
A Duke University study proposes a strategy to better use limited public health care dollars for protecting more people from a sexually transmitted infection called human papillomavirus (HPV) and the cancers it can cause.
Kessler Foundation researchers have received support from Genentech, a member of the Roche Group, to conduct an investigator-initiated study on the effects of ocrelizumab (Ocrevus) on cognitive fatigue in individuals with relapsing-remitting multiple sclerosis (MS).
Research led by the Vall d'Hebron Institute of Oncology (VHIO) evidence the most conclusive preclinical results to-date validating Myc inhibition as a therapeutic strategy in glioma - a highly agressive tumor type that notoriously outsmarts current anti-cancer therapies.
› Verified 8 days ago
Amberly Catherine Wagner-connolly, DNP, MSN, RN Registered Nurse Medicare: Medicare Enrolled Practice Location: 11815 South 216th Street, Gretna, NE 68028 Phone: 402-659-3855 | |
Mrs. Denise D Osborn, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 11717 S 216th St, Gretna, NE 68028 Phone: 402-332-3265 Fax: 402-408-2534 | |
Lori Kanne, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 11717 S 216th St, Gretna, NE 68028 Phone: 402-332-3265 | |
Mrs. Bridget Rachelle Plathe, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 11335 S 204th St, Gretna, NE 68028 Phone: 402-332-3936 Fax: 402-408-2535 | |
Pamela Lynn Gottberg, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 801 South St, Gretna, NE 68028 Phone: 402-332-3341 | |
Mrs. Angela Christine Fichter, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 801 South St, Gretna, NE 68028 Phone: 402-332-3341 |